Aevi Genomic Medicine
$0.1429876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$0.142
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.0022 (-1.52%) Today
-$0.0001 (-0.07%) As of 8:00 PM EST after-hours
Why Robinhood?
You can buy or sell GNMX and other stocks, options, ETFs, and crypto commission-free!
About GNMX
Aevi Genomic Medicine, Inc. Common Stock, also called Aevi Genomic Medicine, is a clinical stage biopharmaceutical company, which engages in finding treatments for rare and orphan diseases. Read More Its research and development efforts leverage an internal genomics platform and an ongoing collaboration with the Center for Applied Genomics (CAG) at The Children's Hospital of Philadelphia (CHOP). The company was founded by Andrew Leonard Pearlman on January 27, 2000 and is headquartered in Wayne, PA.
Employees
14
Headquarters
Wayne, Pennsylvania
Founded
2000
Market Cap
9.35M
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
1.56M
High Today
$0.144
Low Today
$0.1341
Open Price
$0.141
Volume
1.30M
52 Week High
$1.24
52 Week Low
$0.11
Collections
GNMX Earnings
-$0.16
-$0.13
-$0.10
-$0.07
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
—
Actual
Expected Dec 17, Pre-Market